Author:
Wang Ke-Rang,Qian Feng,Wang Xiao-Man,Tan Guan-Hai,Rong Rui-Xue,Cao Zhi-Ran,Chen Hua,Zhang Ping-Zhu,Li Xiao-Liu
Reference31 articles.
1. Naphthalimides as anti-cancer agents: synthesis and biological activity;Braña;Curr. Med. Chem. – Anticancer Agents,2001
2. Naphthalimides and azonafides as promising anti-cancer agents;Ingrassia;Curr. Med. Chem.,2009
3. Overview of naphthalimide analogs as anticancer agents;Lv;Curr. Med. Chem.,2009
4. UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers;Mijatovic;Neoplasia,2008
5. 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity;Quaquebeke;J. Med. Chem.,2007
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献